Profile image
By NHS Choices (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Two older drugs could be ‘repurposed’ to fight dementia

Thursday, April 20, 2017 9:01
% of readers think this story is Fact. Add your two cents.

(Before It's News)

“Depression and cancer drugs offer hope for dementia sufferers,” Sky News reports. The headline is prompted by a study looking at the effect of two drugs – one used to treat depression and another being trialled for cancer treatment – on neurodegenerative diseases.

Neurodegenerative diseases are conditions that cause progressive damage to the brain’s functions, such as Alzheimer’s disease, Parkinson’s disease and CJD (aka “Mad Cow Disease”).

Mice infected with diseases mimicking neurodegenerative diseases were treated with the two drugs: trazodone hydrochloride (used to treat depression and anxiety) and dibenzoylmethane (a drug that could be useful for prostate and bowel cancer).

Both drugs restored memory, reduced signs of neurodegeneration and were safe for the mice in the doses given.

This is exciting early-stage research that might lead to trials in humans to see if they remain safe and effective. An additional bonus is that trazodone has already been licensed for use in older adults, so we have a good understanding of how safe the drug is. This means that clinical trials for trazodone in treating neurodegenerative diseases could conceivably start straight away. But it could take much longer for the drug to come to market for this purpose (and this is not guaranteed to happen).

While there is no guaranteed way to prevent dementia, you may be able to reduce your risk by regular exercise, eating a healthy diet, quitting smoking if you smoke and moderating your consumption of alcohol.

 

Where did the story come from?

The study was carried out by researchers from the University of Cambridge, University of Nottingham and the Medical Research Centre Toxicology Unit in Leicester, UK. The study was funded by the Medical Research Council in the UK and a grant from the Alzheimer’s Society and Alzheimer’s Drug Discovery Foundation.

The study was published on an open-access basis in the peer-reviewed scientific journal Brain, a Journal of Neurology. You can read it for free online or download a PDF version.

The UK media’s reporting of the study was generally accurate and acknowledged that this was early-stage research carried out on mice.

The Mail Online was perhaps a little over-optimistic regarding trazodone, the drug used for depression, suggesting “as it has already been proven safe for humans, it could be on the market in two years”. As research in humans for its potential role in neurodegenerative disorders has not even started, it is likely to be much longer before it can be considered for marketing.

 

What kind of research was this?

This was experimental laboratory research on mice that looked at the effect of different compounds on brain impairment and the nervous system.

Experimental research such as this on mice is necessary to look at the mechanisms of certain drugs that may have an effect on disorders such as dementia. However, as dementia covers a range of complex neurodegenerative disorders which do not affect mice, researchers are only able to study some of the pathways that may be involved.

As the authors acknowledge, this is early-stage research that offers the potential for new treatments for dementia in humans. However, it does not necessarily mean they have discovered a cure or even that the treatment will make it past human clinical trials.

 

What did the research involve?

Researchers looked to restore normal brain functioning in mice that had been infected with neurodegenerative-like diseases by testing two drugs, trazodone hydrochloride and dibenzoylmethane. These two drugs had been whittled down from a list of 1,040 from the National Institute for Neurological Disorders and Stroke, through testing on worms among other things.

A major factor contributing to neurodegenerative diseases such as Alzheimer’s and Parkinson’s is the response to problems with proteins in the brain.

In people with Alzheimer’s, protein production is reduced, causing damage to nerves and memory loss. By “switching” protein production back on, neurodegeneration has been found to be stopped in its tracks. As the compounds that were able to do this were not judged to be suitable for humans, the researchers looked at whether any of the 1,040 drugs also had this effect.

Mice were infected with a prion disease (which can cause CJD), an infectious disease, or a type of genetic dementia, both of which cause neurodegeneration. Seven weeks later, they were treated with either trazodone hydrochloride, a drug used to treat depression, or dibenzoylmethane, a drug currently being trialled as an anti-cancer compound.

The researchers then used an object recognition test to see if mice remembered objects they had already seen and what object was new. They also looked at signs of brain damage as well as brain shrinkage, a sign of neurodegenerative disease.

 

What were the basic results?

Trazodone hydrochloride and dibenzoylmethane restored memory and reduced brain shrinkage, which is a sign of neurodegenerative disease in mice either infected with the prion disease or given a type of genetic dementia.

For the prion-infected mice, survival time was also extended.

Both trazodone hydrochloride and dibenzoylmethane were found to restore protein production in the mice, an indication of neurodegeneration being halted.

Previously, drugs also attempting to reduce neurodegeneration by the same pathway have been found to be toxic to the pancreas. Reassuringly, both drugs were found to be safe for the mice at the given dose and neither were found to be toxic to the pancreas.

 

How did the researchers interpret the results?

The researchers concluded that these two compounds “therefore represent potential new disease-modifying treatments for dementia.”

They suggest that “trazodone in particular, a licensed drug, should now be tested in clinical trials in patients.”

 

Conclusion

This early stage experimental research has demonstrated a beneficial neurological effect of trazodone and dibenzoylmethane on mice with diseases mimicking neurodegenerative diseases.

It is important to acknowledge that this is animal research and therefore the drugs might not have the same effect when they are trialled on humans.

That being said, trazodone is already an approved drug for depression and sleep problems and has therefore already passed safety tests. If the mechanisms of neurodegeneration in humans and mice are similar, it is possible trazodone could be used in the future in treating Alzheimer’s and other neurodegenerative diseases.

These early tests are promising. However, these drugs need to be proven effective and safe in people with neurodegenerative diseases before becoming available.

Even if these are proven safe and effective, it is often a lengthy process from the start of human clinical trials to drugs being marketed and available to healthcare providers. This is especially true for long-term conditions where progression may be slow. Therefore, it could well be several years before these drugs are available for the treatment of neurodegenerative diseases.

Links To The Headlines

Depression and cancer drugs offer hope for dementia sufferers – study. Sky News, April 20 2017

Experts excited by brain ‘wonder-drug’. BBC News, April 20 2017

Could cancer drugs help slow down dementia? ITV News, April 20 2017

Depression drug that could slow Alzheimer’s: Treatment found to reduce brain shrinkage in early tests. Mail Online, April 20 2017

Drug already prescribed to millions of Brits ‘may protect against Alzheimer’s’. The Sun, April 20 2017

Links To Science

Halliday M, Radford H, Zents KAM, et al. Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice. Brain. Published online April 19 2017



Source: http://www.nhs.uk/news/2017/04April/Pages/Two-older-drugs-could-be-repurposed-to-fight-dementia.aspx

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Total 1 comment
  • gracer

    I favor natural supplements for ailments and conditions.
    People taking turmeric have more abnormal brain proteins (amyloid plaque) circulating in their blood. This explains why eating turmeric is linked to lower levels of Alzheimer’s and dementia.
    Turmeric also stops brain cell death and improves mood, and I believe that depression and anxiety could be caused by brain cell death.
    A few months ago I started taking a level teaspoon of turmeric twice a day (morning and evening). Turmeric helps some muscle pain that I have. I bought a 5 lb box for $12.69 or $2.54/lb. The store was WincoFoods located in most western states and Dallas, TX.
    I added a level 1/8 cup of Red Star nutritional yeast also from WincoFoods last week and the effect is very positive.
    So I think natural supplements like these can protect the brain.
    For omega-3, mornings I also take a softgel of “High Potency” tuna DHA 500 mg from PipingRock for perception and well-being. Also, for brain support at breakfast and lunch I take a level teaspoon of Y.S. Eco Bee Farms bee pollen granules from SwansonVitamins.
    For sleep and to relax the nervous system, evenings I take a level tablespoon of non-GMO soy lecithin granules soaked in water, or three 1200 mg softgels of non-GMO soy lecithin.
    Natural supplements are a great way to support the numerous body systems. Mornings I also take a level 1/8 cup of whey protein concentrate powder from NutraBio or BulkSupplements for muscles and hair.
    It’s just a way of life, I guess, taking supplements, but I have cured so many things. Like taking 2 tablespoons of PipingRock’s macadamia oil after meals for 2 months to cure my fungal toenail which dropped off. The toenail grew in healthy over the next year and I still take 1 tablespoon mornings. Or taking 2 capsules of PipingRock’s nopal prickly pear Opuntia cactus after meals to cure itchy skin psoriasis after eating. I still take 1 capsule mornings.
    Or restoring and tightening the cartilage in my loose knee sockets in 3 or 4 months by mornings taking a capsule of chicken sternum cartilage collagen type 2 from PipingRock or SwansonVitamins. After 6 months of 1 daily capsule of chicken sternum a person was able to cancel their hip replacement and their friend canceled a knee replacement and no longer had to sit down from a painful knee while standing in line. Or curing my sensitive teeth and my painful bending knee by mornings taking two NOW brand Calcium Hydroxyapatite Caps from SwansonVitamins. Or curing my gum pain by mornings taking a 500 mg capsule of Swanson hesperidin from SwansonVitamins.
    Then to protect from stroke I take a 40,000 unit Swanson Serrazimes (serrapeptase) at 7 AM and 10 AM. I felt a momentary turbulence go through my carotid arteries the first evening as I laid my head on the pillow. So I now believe I am protected from stroke as long as I take serrapeptase. A person’s carotid artery blockage went from 30% blocked to 10% blocked after six months of taking 120,000 units of Doctor’s Best serrapeptase three times per day.
    I am all for natural supplements and for letting nature heal things the right way.

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.